Virax Biolabs Group Limited announced that it will receive $2,150,000 in funding on October 12, 2023. The company will issue Convertible Preferred Shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | +16.37% | +15.87% | -50.00% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.00% | 1.72M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.11% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it expects to receive $2.15 million in funding